Spiriva
Active Ingredient(s): TiotropiumFDA Approved: * January 30, 2004
Pharm Company: * BOEHRINGER INGELHEIM
Category: Lungs (Pulmonary)
Tiotropium bromide, sold under the brand name Spiriva among others, is a long-acting bronchodilator used in the management of chronic obstructive pulmonary disease (COPD) and asthma.[10][11] Specifically it is used during periods of breathing difficulty to prevent them from getting worse, rather than to prevent them from happening.[10] It is used by inhalation through the mouth.[10] Onset typically begins within half an hour and ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.41 Discussions
Dosage List
Related Brands
Drugs with the same active ingredientsPopular Topics
I've talked about this problem before concerning the side effects from Spiriva. The only side effect I've experi...
216 REPLIESHello. I took Spiriva inhaler a couple of years ago for six weeks and gained an unsightly 22 lbs that I cannot get rid o...
9 REPLIESplease when a person has been taking this(*Spiriva) medication for a period of time you know if you are getting meds or ...
6 REPLIESI have had one or two duds per box of Spiriva. That is when they do not rattle and the capsule breaks. I think it is due...
2 REPLIESI've mentioned this once before and I will again. I've posted my problem with Spiriva and serious weight gain pr...
2 REPLIESI've had a problem with Spiriva and weight gain (lots of discussion about that elsewhere on this website), but now I...
2 REPLIESHow much are you paying for a 30 day supply of Spiriva? just trying to get an idea of general costs of this drug. ## Bas...
2 REPLIESI took Spiriva the 1st time for 3 weeks and gavce up on it.My doctor says I have to give it a lot more time to show it,s...
2 REPLIESI was prescribed this medication about 4 months ago--started 3 weeks ago--no improvement in sats, swollen eyelids, cough...
1 REPLYhaving very bad side effects, such as, CONSTIPATION HOW TO OVER-COME THIS SIDE EFFECTS? ## The only way to overcome side...
1 REPLY